Sign inJoin waitlistJoin the waitlist

Silva Markovic-Plese

Professor, Department of Neurology · SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY

Credentials: · · · · ·

History

SIDNEY KIMMEL MEDICAL COLLEGE AT THOMAS JEFFERSON UNIVERSITY
Present

Neurology
Yale Univ Sch of Med
1996–1999
Harvard University
1988–1989
UNIV OF ZAGREB, SPLIT BRANCH, SCH OF MED, SPLIT, CROATIA
1984–1988

Research

Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with…
The Journal of Experimental Medicine · 1994 · 446 citations
Oral simvastatin treatment in relapsing-remitting multiple sclerosis
The Lancet · 2004 · 385 citations
Aggresomes protect cells by enhancing the degradation of toxic polyglutamine-containing protein
Human Molecular Genetics · 2003 · 358 citations

Valerie Jewells
7 papers
Bianca Weinstock-Guttman
6 papers
FD
Fernando Dangond
6 papers
BB
Bibiana Bielekova
3 papers
DS
Danielle Speer
3 papers
David Hojnacki
3 papers
Luigi Troiani
3 papers
Nazanin Kiapour
3 papers
Sahil Kapoor
3 papers
Barbara Giesser
2 papers
DH
David Hafler
2 papers
Eric Lindzen
2 papers · 1 as a fellow

Grants

Immunoregulatory Effect of Microparticle Delivered STING Agonist in the Control of Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $430.9K · Thomas Jefferson University
2021–2024
The Role of IL-II in the Development of Autoimmune Response in Multiple Sclerosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · Thomas Jefferson University
2018–2023
The Role of IL-11 in Development of Th17-Mediated Autoimmune Response in EAE
National Institute of Allergy and Infectious Diseases · R03
Contact PI · $152K · Univ of North Carolina Chapel Hill
2014–2016
The Mechanisms of Autoimmune Response Initiation in Multiple Sclerosis
National Institute of Neurological Disorders and Stroke · K08
Contact PI · $828.1K · Univ of North Carolina Chapel Hill
2003–2008

Clinical trials

IL-11 in the Development of Multiple Sclerosis
Principal investigator · Unknown
Thomas Jefferson University
2018–2023
Teriflunomide's Therapeutic Mechanisms of Action in Patients With Relapsing Remitting Multiple Sclerosis.
Principal investigator · Terminated
University of North Carolina, Chapel Hill
2016
Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells
Principal investigator · Completed
University of North Carolina, Chapel Hill
2007–2011
EARLY IFNb-1a and Atorvastatin Combination Therapy of Isolated Clinical Syndrome Suggestive of Multiple Sclerosis
Principal investigator · Completed
University of North Carolina, Chapel Hill
2004–2008